In this study, we aimed to explore the correlation between ZEB1 protein expression and neoadjuvant chemotherapy sensitivity in patients from our weekly paclitaxel- and cisplatin-based neoadjuvant trial in breast cancer. Here, ZEB1 is linked to breast cancer.